Colonoscope Market By Application (Colorectal Cancer, Ulcerative Colitis, Crohns Disease, Others), By End User (Hospitals, Ambulatory Surgery Centers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

Colonoscope Market

Colonoscopes are the devices that are designed for examining the whole colon and terminal ileum. It is because of the flexibility of the colon where it is not tethered and there is a tendency for the colonoscope to form loops. The colonoscope is designed to minimize loop formation by differences in the flexibility throughout the length of the insertion tube. Its application ranges from colorectal screening and evaluation of anemia to therapeutic interventions such as polypectomy and palliative stenting.

Key factors driving the growth of the colonoscope market include rise in geriatric population and surge in adoption of colonoscope systems to facilitate better diagnosis of colon diseases. Moreover, increase in incidence of colon related diseases, rise in demand for healthcare services for the aging population and continuous developments in the field of colonoscopy is expected to notably contribute toward the market growth. Furthermore, the global colonoscopes market growth is largely boosted by factors such as an increase in advancements of colonoscope which is surely expected to lead the growth of the market. Prominent players in the global colonoscopes market have opted various strategies such as product launch, acquisition, and investments in R&D for advancement in colonoscopes to strengthen their position in the market and sustain the competitive environment. For instance, in August 2020, Olympus Corporation announced that it has signed a definitive agreement to acquire Arc Medical Design Limited (Arc Medical Design), a subsidiary of Norgine B.V. The acquisition underscored Olympus’ commitment to expanding its offering in gastrointestinal therapeutic devices and the development of advanced colonoscopy tools through M&A (mergers and acquisitions) opportunities as well as through R&D (research and development) with the overarching goal of improving early detection and treatment of colorectal cancer.

A significant increase in awareness about the advantages of colonoscope, rise in the usage of this device in the screening, and surge in the number of patients suffering from colon related diseases are some of the other key factors driving the growth of the market. However, risks of complications during the colonoscopy and high cost of the device restricts the market growth. Conversely, the introduction of new and advanced products has changed the market dynamics during the forecast period and is expected to provide lucrative opportunities for the growth of the market. Extensive R&D activities in the field of medical devices along with significant improvement in medical infrastructure are anticipated to open new avenues for the expansion of the market.

The global colonoscopes market is segmented on the basis of application, end user and region. On the basis of application, the market is divided into colorectal cancer, ulcerative colitis, Crohns disease and others. On the basis of end user, the market is categorized into hospitals, ambulatory surgery centers and others. Region wise, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

The key players profiled in the study include Olympus Corporation, Stryker Corporation, FUJIFILM Holdings Corporation, Medtronic Plc, Boston Scientific Corporation, PENTAX Medical, Endomed System, Sonoscape Medical Corporation, Ambu A/S, and Endofresh. The players in the market have been actively engaged in the adoption various strategies such as acquisition, product launch, partnership, product approval and product development to remain competitive and gain an advantage over the competitors in the market. For instance, in August 2022, Olympus Corporation (Olympus), announced their part in a project in collaboration with the Ministry of Internal Affairs and Communications of Japan (MIC), entitled, “Survey Study for International Expansion of Endoscopes Utilizing High-definition Imaging Technology AI Diagnosis Support System in Vietnam.”. Olympus previously has researched clinical applications in collaboration with major local medical institutions.                                                                                                                                       

Key Market Insights (Updated)

By application, the others segment was the highest revenue contributor to the market and is estimated to continue this during the analysis period, with a CAGR of 7.1%. However, the ulcerative colitis segment is estimated to be the fastest-growing segment with a CAGR of 8.4% during the forecast period.

By end user, the hospitals segment was the highest revenue contributor to the market and is estimated to continue this during the analysis period, with a CAGR of 7.5%. However, the ambulatory surgery centers segment is estimated to be the fastest-growing segment with a CAGR of 8.0% during the forecast period.

Based on region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR of 8.9% during the forecast period.

Overview

The global colonoscope market was valued at $1.2 billion in 2021, and is projected to reach $2.5 billion by 2031, growing at a CAGR of 7.6% from 2022 to 2031.  

A colonoscope is a flexible fiber-optic instrument inserted through the anus to examine the colon. It is helpful for diagnosing gastrointestinal diseases, such as inflammatory bowel disease and colon cancer. It can also help treat and prevent colon cancer. Healthcare providers recommend routine colonoscopies for middle-aged and older adults to screen for cancer. Most people have their first colonoscopy for routine cancer screening. Statistically, the risk of developing colorectal cancer goes up as age increases, which is why the American Cancer Society recommends regular screening at least by the age of 45. The colonoscope also allows for therapeutic actions like a dedicated tool could be introduced through the instrument port to perform a biopsy or removal of cancerous lesions. A gut version of skin prick testing using local reactions to food injected into the colonic mucosa via the colonoscope appears to have a better predictive value but is not widely applied.  

The growth of the colonoscopes market is driven by an increase in incidence of colon related diseases, rise in demand for healthcare services for the aging population and continuous developments in the field of colonoscopy. Moreover, rise in geriatric population and surge in adoption of colonoscope systems to facilitate better diagnosis of colon diseases is expected to notably contribute toward the market growth. Furthermore, the global colonoscopes market growth is largely driven by factors such as an increase in advancements of colonoscope which is surely expected to lead the growth of the market. Prominent players in the global colonoscopes market have opted various strategies such as product launch, acquisition, and investments in R&D for advancement in colonoscopes to strengthen their position in the market and sustain the competitive environment. For instance, in 2022, SMART Medical Systems Ltd., announced an additional FDA clearance for its G-EYE Colonoscope which is based on Olympus' PCF colonoscope series which is also 510(k) cleared. With this additional FDA clearance, G-EYE is available for use in the U.S. market on the commonly used colonoscope models of all three leading endoscopy brands namely OLYMPUS, FUJIFILM, and PENTAX Medical.  

A significant increase in awareness about the advantages of colonoscope, rise in the usage of this device in the screening, and surge in the number of patients suffering from colon related diseases are some of the other key factors driving the growth of the market. However, risks of complications during the colonoscopy and high cost of the device restricts the market growth. Conversely, the introduction of new and advanced products has changed the market dynamics during the forecast period and is expected to provide lucrative opportunities for the growth of the market. Extensive R&D activities in the field of medical devices along with significant improvement in medical infrastructure are anticipated to open new avenues for the expansion of the market.  

The global colonoscopes market is segmented on the basis of application, end user and region. On the basis of application, the market is divided into colorectal cancer, ulcerative colitis, Crohns disease and others. On the basis of end user, the market is categorized into hospitals, ambulatory surgery centers and others. Region wise, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).  

Major companies profiled in the report include Olympus Corporation, Stryker Corporation, FUJIFILM Holdings Corporation, Medtronic Plc, Boston Scientific Corporation, PENTAX Medical, Endomed System, Sonoscape Medical Corporation, Ambu A/S, and Endofresh. 

Key Benefits For Stakeholders

●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the colonoscope market analysis from 2021 to 2031 to identify the prevailing colonoscope market opportunities.

●The market research is offered along with information related to key drivers, restraints, and opportunities.

●Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

●In-depth analysis of the colonoscope market segmentation assists to determine the prevailing market opportunities.

●Major countries in each region are mapped according to their revenue contribution to the global market.

●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

●The report includes the analysis of the regional as well as global colonoscope market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

○ Endomed System

Scope of Colonoscope Market Report

1.1. Report description

1.2. Key market segments

1.3. Key benefits to the stakeholders

1.4. Research Methodology

1.4.1. Primary research

1.4.2. Secondary research

1.4.3. Analyst tools and models

2.1. CXO Perspective

3.1. Market definition and scope

3.2. Key findings

3.2.1. Top impacting factors

3.2.2. Top investment pockets

3.3. Porter’s five forces analysis

3.3.1. Bargaining power of suppliers

3.3.2. Bargaining power of buyers

3.3.3. Threat of substitutes

3.3.4. Threat of new entrants

3.3.5. Intensity of rivalry

3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Increase in the prevalence of colon cancer

3.4.1.2. Rise in technological advancement in colonoscope imaging

3.4.1.3. Increase in preference of population towards minimally invasive techniques

3.4.2. Restraints

3.4.2.1. High risks involved during the colonoscopy procedures

3.4.3. Opportunities

3.4.3.1. Surge in usage of colonoscope in healthcare facilities applications

3.5. COVID-19 Impact Analysis on the market

4.1. Overview

4.1.1. Market size and forecast

4.2. Colorectal Cancer

4.2.1. Key market trends, growth factors and opportunities

4.2.2. Market size and forecast, by region

4.2.3. Market share analysis by country

4.3. Ulcerative Colitis

4.3.1. Key market trends, growth factors and opportunities

4.3.2. Market size and forecast, by region

4.3.3. Market share analysis by country

4.4. Crohns Disease

4.4.1. Key market trends, growth factors and opportunities

4.4.2. Market size and forecast, by region

4.4.3. Market share analysis by country

4.5. Others

4.5.1. Key market trends, growth factors and opportunities

4.5.2. Market size and forecast, by region

4.5.3. Market share analysis by country

5.1. Overview

5.1.1. Market size and forecast

5.2. Hospitals

5.2.1. Key market trends, growth factors and opportunities

5.2.2. Market size and forecast, by region

5.2.3. Market share analysis by country

5.3. Ambulatory Surgery Centers

5.3.1. Key market trends, growth factors and opportunities

5.3.2. Market size and forecast, by region

5.3.3. Market share analysis by country

5.4. Others

5.4.1. Key market trends, growth factors and opportunities

5.4.2. Market size and forecast, by region

5.4.3. Market share analysis by country

6.1. Overview

6.1.1. Market size and forecast By Region

6.2. North America

6.2.1. Key trends and opportunities

6.2.2. Market size and forecast, by Application

6.2.3. Market size and forecast, by End User

6.2.4. Market size and forecast, by country

6.2.4.1. U.S.

6.2.4.1.1. Key market trends, growth factors and opportunities

6.2.4.1.2. Market size and forecast, by Application

6.2.4.1.3. Market size and forecast, by End User

6.2.4.2. Canada

6.2.4.2.1. Key market trends, growth factors and opportunities

6.2.4.2.2. Market size and forecast, by Application

6.2.4.2.3. Market size and forecast, by End User

6.2.4.3. Mexico

6.2.4.3.1. Key market trends, growth factors and opportunities

6.2.4.3.2. Market size and forecast, by Application

6.2.4.3.3. Market size and forecast, by End User

6.3. Europe

6.3.1. Key trends and opportunities

6.3.2. Market size and forecast, by Application

6.3.3. Market size and forecast, by End User

6.3.4. Market size and forecast, by country

6.3.4.1. Germany

6.3.4.1.1. Key market trends, growth factors and opportunities

6.3.4.1.2. Market size and forecast, by Application

6.3.4.1.3. Market size and forecast, by End User

6.3.4.2. France

6.3.4.2.1. Key market trends, growth factors and opportunities

6.3.4.2.2. Market size and forecast, by Application

6.3.4.2.3. Market size and forecast, by End User

6.3.4.3. UK

6.3.4.3.1. Key market trends, growth factors and opportunities

6.3.4.3.2. Market size and forecast, by Application

6.3.4.3.3. Market size and forecast, by End User

6.3.4.4. Italy

6.3.4.4.1. Key market trends, growth factors and opportunities

6.3.4.4.2. Market size and forecast, by Application

6.3.4.4.3. Market size and forecast, by End User

6.3.4.5. Spain

6.3.4.5.1. Key market trends, growth factors and opportunities

6.3.4.5.2. Market size and forecast, by Application

6.3.4.5.3. Market size and forecast, by End User

6.3.4.6. Rest of Europe

6.3.4.6.1. Key market trends, growth factors and opportunities

6.3.4.6.2. Market size and forecast, by Application

6.3.4.6.3. Market size and forecast, by End User

6.4. Asia-Pacific

6.4.1. Key trends and opportunities

6.4.2. Market size and forecast, by Application

6.4.3. Market size and forecast, by End User

6.4.4. Market size and forecast, by country

6.4.4.1. China

6.4.4.1.1. Key market trends, growth factors and opportunities

6.4.4.1.2. Market size and forecast, by Application

6.4.4.1.3. Market size and forecast, by End User

6.4.4.2. Japan

6.4.4.2.1. Key market trends, growth factors and opportunities

6.4.4.2.2. Market size and forecast, by Application

6.4.4.2.3. Market size and forecast, by End User

6.4.4.3. India

6.4.4.3.1. Key market trends, growth factors and opportunities

6.4.4.3.2. Market size and forecast, by Application

6.4.4.3.3. Market size and forecast, by End User

6.4.4.4. Australia

6.4.4.4.1. Key market trends, growth factors and opportunities

6.4.4.4.2. Market size and forecast, by Application

6.4.4.4.3. Market size and forecast, by End User

6.4.4.5. South Korea

6.4.4.5.1. Key market trends, growth factors and opportunities

6.4.4.5.2. Market size and forecast, by Application

6.4.4.5.3. Market size and forecast, by End User

6.4.4.6. Rest of Asia-Pacific

6.4.4.6.1. Key market trends, growth factors and opportunities

6.4.4.6.2. Market size and forecast, by Application

6.4.4.6.3. Market size and forecast, by End User

6.5. LAMEA

6.5.1. Key trends and opportunities

6.5.2. Market size and forecast, by Application

6.5.3. Market size and forecast, by End User

6.5.4. Market size and forecast, by country

6.5.4.1. Brazil

6.5.4.1.1. Key market trends, growth factors and opportunities

6.5.4.1.2. Market size and forecast, by Application

6.5.4.1.3. Market size and forecast, by End User

6.5.4.2. Saudi Arabia

6.5.4.2.1. Key market trends, growth factors and opportunities

6.5.4.2.2. Market size and forecast, by Application

6.5.4.2.3. Market size and forecast, by End User

6.5.4.3. South Africa

6.5.4.3.1. Key market trends, growth factors and opportunities

6.5.4.3.2. Market size and forecast, by Application

6.5.4.3.3. Market size and forecast, by End User

6.5.4.4. Rest of LAMEA

6.5.4.4.1. Key market trends, growth factors and opportunities

6.5.4.4.2. Market size and forecast, by Application

6.5.4.4.3. Market size and forecast, by End User

7.1. Introduction

7.2. Top winning strategies

7.3. Product Mapping of Top 10 Player

7.4. Competitive Dashboard

7.5. Competitive Heatmap

7.6. Top player positioning, 2021

8.1. Olympus Corporation

8.1.1. Company overview

8.1.2. Key Executives

8.1.3. Company snapshot

8.1.4. Operating business segments

8.1.5. Product portfolio

8.1.6. Business performance

8.1.7. Key strategic moves and developments

8.2. Stryker Corporation

8.2.1. Company overview

8.2.2. Key Executives

8.2.3. Company snapshot

8.2.4. Operating business segments

8.2.5. Product portfolio

8.2.6. Business performance

8.2.7. Key strategic moves and developments

8.3. Pentax Medical

8.3.1. Company overview

8.3.2. Key Executives

8.3.3. Company snapshot

8.3.4. Operating business segments

8.3.5. Product portfolio

8.4. Fujifilm Holdings

8.4.1. Company overview

8.4.2. Key Executives

8.4.3. Company snapshot

8.4.4. Operating business segments

8.4.5. Product portfolio

8.4.6. Business performance

8.4.7. Key strategic moves and developments

8.5. Medtronic plc

8.5.1. Company overview

8.5.2. Key Executives

8.5.3. Company snapshot

8.5.4. Operating business segments

8.5.5. Product portfolio

8.5.6. Business performance

8.5.7. Key strategic moves and developments

8.6. Boston Scientific Corporation

8.6.1. Company overview

8.6.2. Key Executives

8.6.3. Company snapshot

8.6.4. Operating business segments

8.6.5. Product portfolio

8.6.6. Business performance

8.6.7. Key strategic moves and developments

8.7. Endomed Systems

8.7.1. Company overview

8.7.2. Key Executives

8.7.3. Company snapshot

8.7.4. Operating business segments

8.7.5. Product portfolio

8.8. Sonoscape Medical Corp.

8.8.1. Company overview

8.8.2. Key Executives

8.8.3. Company snapshot

8.8.4. Operating business segments

8.8.5. Product portfolio

8.9. Ambu A/S

8.9.1. Company overview

8.9.2. Key Executives

8.9.3. Company snapshot

8.9.4. Operating business segments

8.9.5. Product portfolio

8.9.6. Business performance

8.9.7. Key strategic moves and developments

8.10. Endofresh

8.10.1. Company overview

8.10.2. Key Executives

8.10.3. Company snapshot

8.10.4. Operating business segments

8.10.5. Product portfolio

8.10.6. Key strategic moves and development

LIST OF TABLES

TABLE 01. GLOBAL COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 02. COLONOSCOPE MARKET FOR COLORECTAL CANCER, BY REGION, 2021-2031 ($MILLION)

TABLE 03. COLONOSCOPE MARKET FOR ULCERATIVE COLITIS, BY REGION, 2021-2031 ($MILLION)

TABLE 04. COLONOSCOPE MARKET FOR CROHNS DISEASE, BY REGION, 2021-2031 ($MILLION)

TABLE 05. COLONOSCOPE MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)

TABLE 06. GLOBAL COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 07. COLONOSCOPE MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)

TABLE 08. COLONOSCOPE MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2021-2031 ($MILLION)

TABLE 09. COLONOSCOPE MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)

TABLE 10. COLONOSCOPE MARKET, BY REGION, 2021-2031 ($MILLION)

TABLE 11. NORTH AMERICA COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 12. NORTH AMERICA COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 13. NORTH AMERICA COLONOSCOPE MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 14. U.S. COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 15. U.S. COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 16. CANADA COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 17. CANADA COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 18. MEXICO COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 19. MEXICO COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 20. EUROPE COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 21. EUROPE COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 22. EUROPE COLONOSCOPE MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 23. GERMANY COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 24. GERMANY COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 25. FRANCE COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 26. FRANCE COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 27. UK COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 28. UK COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 29. ITALY COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 30. ITALY COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 31. SPAIN COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 32. SPAIN COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 33. REST OF EUROPE COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 34. REST OF EUROPE COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 35. ASIA-PACIFIC COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 36. ASIA-PACIFIC COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 37. ASIA-PACIFIC COLONOSCOPE MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 38. CHINA COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 39. CHINA COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 40. JAPAN COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 41. JAPAN COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 42. INDIA COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 43. INDIA COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 44. AUSTRALIA COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 45. AUSTRALIA COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 46. SOUTH KOREA COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 47. SOUTH KOREA COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 48. REST OF ASIA-PACIFIC COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 49. REST OF ASIA-PACIFIC COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 50. LAMEA COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 51. LAMEA COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 52. LAMEA COLONOSCOPE MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 53. BRAZIL COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 54. BRAZIL COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 55. SAUDI ARABIA COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 56. SAUDI ARABIA COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 57. SOUTH AFRICA COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 58. SOUTH AFRICA COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 59. REST OF LAMEA COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 60. REST OF LAMEA COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 61. OLYMPUS CORPORATION: KEY EXECUTIVES

TABLE 62. OLYMPUS CORPORATION: COMPANY SNAPSHOT

TABLE 63. OLYMPUS CORPORATION: PRODUCT SEGMENTS

TABLE 64. OLYMPUS CORPORATION: PRODUCT PORTFOLIO

TABLE 65. OLYMPUS CORPORATION: KEY STRATERGIES

TABLE 66. STRYKER CORPORATION: KEY EXECUTIVES

TABLE 67. STRYKER CORPORATION: COMPANY SNAPSHOT

TABLE 68. STRYKER CORPORATION: PRODUCT SEGMENTS

TABLE 69. STRYKER CORPORATION: PRODUCT PORTFOLIO

TABLE 70. STRYKER CORPORATION: KEY STRATERGIES

TABLE 71. PENTAX MEDICAL: KEY EXECUTIVES

TABLE 72. PENTAX MEDICAL: COMPANY SNAPSHOT

TABLE 73. PENTAX MEDICAL: SERVICE SEGMENTS

TABLE 74. PENTAX MEDICAL: PRODUCT PORTFOLIO

TABLE 75. FUJIFILM HOLDINGS: KEY EXECUTIVES

TABLE 76. FUJIFILM HOLDINGS: COMPANY SNAPSHOT

TABLE 77. FUJIFILM HOLDINGS: SERVICE SEGMENTS

TABLE 78. FUJIFILM HOLDINGS: PRODUCT PORTFOLIO

TABLE 79. FUJIFILM HOLDINGS: KEY STRATERGIES

TABLE 80. MEDTRONIC PLC: KEY EXECUTIVES

TABLE 81. MEDTRONIC PLC: COMPANY SNAPSHOT

TABLE 82. MEDTRONIC PLC: PRODUCT SEGMENTS

TABLE 83. MEDTRONIC PLC: PRODUCT PORTFOLIO

TABLE 84. MEDTRONIC PLC: KEY STRATERGIES

TABLE 85. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES

TABLE 86. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT

TABLE 87. BOSTON SCIENTIFIC CORPORATION: PRODUCT SEGMENTS

TABLE 88. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO

TABLE 89. BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES

TABLE 90. ENDOMED SYSTEMS: KEY EXECUTIVES

TABLE 91. ENDOMED SYSTEMS: COMPANY SNAPSHOT

TABLE 92. ENDOMED SYSTEMS: PRODUCT SEGMENTS

TABLE 93. ENDOMED SYSTEMS: PRODUCT PORTFOLIO

TABLE 94. SONOSCAPE MEDICAL CORP.: KEY EXECUTIVES

TABLE 95. SONOSCAPE MEDICAL CORP.: COMPANY SNAPSHOT

TABLE 96. SONOSCAPE MEDICAL CORP.: SERVICE SEGMENTS

TABLE 97. SONOSCAPE MEDICAL CORP.: PRODUCT PORTFOLIO

TABLE 98. AMBU A/S: KEY EXECUTIVES

TABLE 99. AMBU A/S: COMPANY SNAPSHOT

TABLE 100. AMBU A/S: PRODUCT SEGMENTS

TABLE 101. AMBU A/S: PRODUCT PORTFOLIO

TABLE 102. AMBU A/S: KEY STRATERGIES

TABLE 103. ENDOFRESH: KEY EXECUTIVES

TABLE 104. ENDOFRESH: COMPANY SNAPSHOT

TABLE 105. ENDOFRESH: PRODUCT SEGMENTS

TABLE 106. ENDOFRESH: SERVICE SEGMENTS

TABLE 107. ENDOFRESH: PRODUCT PORTFOLIO

TABLE 108. ENDOFRESH: KEY STRATERGIES LIST OF FIGURES

FIGURE 01. COLONOSCOPE MARKET, 2021-2031

FIGURE 02. SEGMENTATION OF COLONOSCOPE MARKET, 2021-2031

FIGURE 03. TOP INVESTMENT POCKETS IN COLONOSCOPE MARKET (2022-2031)

FIGURE 04. HIGH BARGAINING POWER OF SUPPLIERS

FIGURE 05. MODERATE BARGAINING POWER OF BUYERS

FIGURE 06. MODERATE THREAT OF SUBSTITUTES

FIGURE 07. MODERATE THREAT OF NEW ENTRANTS

FIGURE 08. MODERATE INTENSITY OF RIVALRY

FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALCOLONOSCOPE MARKET

FIGURE 10. COLONOSCOPE MARKET, BY APPLICATION, 2021(%)

FIGURE 11. COMPARATIVE SHARE ANALYSIS OF COLONOSCOPE MARKET FOR COLORECTAL CANCER, BY COUNTRY 2021-2031(%)

FIGURE 12. COMPARATIVE SHARE ANALYSIS OF COLONOSCOPE MARKET FOR ULCERATIVE COLITIS, BY COUNTRY 2021-2031(%)

FIGURE 13. COMPARATIVE SHARE ANALYSIS OF COLONOSCOPE MARKET FOR CROHNS DISEASE, BY COUNTRY 2021-2031(%)

FIGURE 14. COMPARATIVE SHARE ANALYSIS OF COLONOSCOPE MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)

FIGURE 15. COLONOSCOPE MARKET, BY END USER, 2021(%)

FIGURE 16. COMPARATIVE SHARE ANALYSIS OF COLONOSCOPE MARKET FOR HOSPITALS, BY COUNTRY 2021-2031(%)

FIGURE 17. COMPARATIVE SHARE ANALYSIS OF COLONOSCOPE MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY 2021-2031(%)

FIGURE 18. COMPARATIVE SHARE ANALYSIS OF COLONOSCOPE MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)

FIGURE 19. COLONOSCOPE MARKET BY REGION, 2021

FIGURE 20. U.S. COLONOSCOPE MARKET, 2021-2031 ($MILLION)

FIGURE 21. CANADA COLONOSCOPE MARKET, 2021-2031 ($MILLION)

FIGURE 22. MEXICO COLONOSCOPE MARKET, 2021-2031 ($MILLION)

FIGURE 23. GERMANY COLONOSCOPE MARKET, 2021-2031 ($MILLION)

FIGURE 24. FRANCE COLONOSCOPE MARKET, 2021-2031 ($MILLION)

FIGURE 25. UK COLONOSCOPE MARKET, 2021-2031 ($MILLION)

FIGURE 26. ITALY COLONOSCOPE MARKET, 2021-2031 ($MILLION)

FIGURE 27. SPAIN COLONOSCOPE MARKET, 2021-2031 ($MILLION)

FIGURE 28. REST OF EUROPE COLONOSCOPE MARKET, 2021-2031 ($MILLION)

FIGURE 29. CHINA COLONOSCOPE MARKET, 2021-2031 ($MILLION)

FIGURE 30. JAPAN COLONOSCOPE MARKET, 2021-2031 ($MILLION)

FIGURE 31. INDIA COLONOSCOPE MARKET, 2021-2031 ($MILLION)

FIGURE 32. AUSTRALIA COLONOSCOPE MARKET, 2021-2031 ($MILLION)

FIGURE 33. SOUTH KOREA COLONOSCOPE MARKET, 2021-2031 ($MILLION)

FIGURE 34. REST OF ASIA-PACIFIC COLONOSCOPE MARKET, 2021-2031 ($MILLION)

FIGURE 35. BRAZIL COLONOSCOPE MARKET, 2021-2031 ($MILLION)

FIGURE 36. SAUDI ARABIA COLONOSCOPE MARKET, 2021-2031 ($MILLION)

FIGURE 37. SOUTH AFRICA COLONOSCOPE MARKET, 2021-2031 ($MILLION)

FIGURE 38. REST OF LAMEA COLONOSCOPE MARKET, 2021-2031 ($MILLION)

FIGURE 39. TOP WINNING STRATEGIES, BY YEAR

FIGURE 40. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 41. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 42. PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 43. COMPETITIVE DASHBOARD

FIGURE 44. COMPETITIVE HEATMAP: COLONOSCOPE MARKET

FIGURE 45. TOP PLAYER POSITIONING, 2021

FIGURE 46. OLYMPUS CORPORATION: NET REVENUE, 2019-2021 ($MILLION)

FIGURE 47. OLYMPUS CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 48. OLYMPUS CORPORATION: REVENUE SHARE BY REGION, 2021 (%)

FIGURE 49. STRYKER CORPORATION: NET REVENUE, 2019-2021 ($MILLION)

FIGURE 50. STRYKER CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 51. STRYKER CORPORATION: REVENUE SHARE BY REGION, 2021 (%)

FIGURE 52. FUJIFILM HOLDINGS: NET REVENUE, 2019-2021 ($MILLION)

FIGURE 53. FUJIFILM HOLDINGS: REVENUE SHARE BY REGION, 2021 (%)

FIGURE 54. FUJIFILM HOLDINGS: REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 55. MEDTRONIC PLC: NET SALES, 2020-2022 ($MILLION)

FIGURE 56. MEDTRONIC PLC: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 57. MEDTRONIC PLC: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 58. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2019-2021 ($MILLION)

FIGURE 59. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 60. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE BY REGION, 2021 (%)

FIGURE 61. AMBU A/S: NET REVENUE, 2020-2022 ($MILLION)

FIGURE 62. AMBU A/S: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 63. AMBU A/S: REVENUE SHARE BY REGION, 2022 (%